Publications by authors named "Gili Hart"

Claim this Profile
A
A phase I study assessing the safety and tolerability of SPL84, an inhaled antisense oligonucleotide for treatment of cystic fibrosis patients with the 3849 +10kb C->T.
Yoseph Caraco, Maor Wanounou, Simcha Blotnick, Lital Friedman, Asaf Cohen, Gili Hart

J Cyst Fibros· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and toxicity profile of SPL84, an inhaled antisense oligonucleotide for treatment of cystic fibrosis patients with the 3849 +10kb C->T mutation, supports a Phase 1/2 clinical study.
Lital Friedman, Ofra-Barchad Avitzur, Efrat Ozeri Galai, Nicolay Ferrari, Asa Choen, Gili Hart

Expert Opin Drug Metab Toxicol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide Drug for 3849 + 10 kb C- > T Cystic Fibrosis Patients.
Efrat Ozeri-Galai, Lital Friedman, Ofra Barchad-Avitzur, Matthew R Markovetz, William Boone, Gili Hart

Nucleic Acid Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Pharmacodynamics, and Safety of a Long-Acting Human Growth Hormone (MOD-4023) in Healthy Japanese and Caucasian Adults.
William G Kramer, Michal Jaron-Mendelson, Ronit Koren, Oren Hershkovitz, Gili Hart

Clin Pharmacol Drug Dev· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and Pharmacodynamic Modeling of MOD-4023, a Long-Acting Human Growth Hormone, in Growth Hormone Deficiency Children.
Dennis M Fisher, Ron G Rosenfeld, Michal Jaron-Mendelson, Leanne Amitzi, Ronit Koren, Gili Hart

Horm Res Paediatr· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Acting C-Terminal Peptide-Modified hGH (MOD-4023): Results of a Safety and Dose-Finding Study in GHD Children.
Nataliya Zelinska, Violeta Iotova, Julia Skorodok, Oleg Malievsky, Valentina Peterkova, Gili Hart

J Clin Endocrinol Metab· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.
Christian J Strasburger, Peter Vanuga, Juraj Payer, Marija Pfeifer, Vera Popovic, Gili Hart

Eur J Endocrinol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD151 Regulates T-Cell Migration in Health and Inflammatory Bowel Disease.
Einat Zelman-Toister, Eszter Bakos, Sivan Cohen, Ehud Zigmond, Elias Shezen, Gili Hart

Inflamm Bowel Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro and in Vivo Characterization of MOD-4023, a Long-Acting Carboxy-Terminal Peptide (CTP)-Modified Human Growth Hormone.
Oren Hershkovitz, Ahuva Bar-Ilan, Rachel Guy, Yana Felikman, Laura Moschcovich, Gili Hart

Mol Pharm· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD74 is a survival receptor on colon epithelial cells.
Nitsan Maharshak, Sivan Cohen, Frida Lantner, Gili Hart, Lin Leng

World J Gastroenterol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mad3 negatively regulates B cell differentiation in the spleen by inducing Id2 expression.
Yael Gore, Frida Lantner, Gili Hart, Idit Shachar

Mol Biol Cell· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory effects of an inflammatory chemokine: CCL2 inhibits lymphocyte homing by modulation of CCL21-triggered integrin-mediated adhesions.
Liat Flaishon, Gili Hart, Einat Zelman, Christine Moussion, Valentin Grabovsky

Blood· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-15 regulates immature B-cell homing in an Ly49D-, IL-12 , and IL-18 dependent manner.
Gili Hart, Tamar Avin-Wittenberg, Idit Shachar

Blood· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-12 and IL-18 down-regulate B cell migration in an Ly49D-dependent manner.
Gili Hart, Liat Flaishon, Idit Shachar

Eur J Immunol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tight regulation of IFN-gamma transcription and secretion in immature and mature B cells by the inhibitory MHC class I receptor, Ly49G2.
Gili Hart, Liat Flaishon, Shirly Becker-Herman, Idit Shachar

J Immunol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the chemokine receptor CCR2 on immature B cells negatively regulates their cytoskeletal rearrangement and migration.
Liat Flaishon, Shirly Becker-Herman, Gili Hart, Yoram Levo, William A Kuziel

Blood· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ly49D receptor expressed on immature B cells regulates their IFN-gamma secretion, actin polymerization, and homing.
Gili Hart, Liat Flaishon, Shirly Becker-Herman, Idit Shachar

J Immunol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis